Lv5
930 积分 2025-01-14 加入
Advances and challenges in targeting FGFR signalling in cancer
4小时前
已完结
Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy
25天前
已完结
CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling
26天前
已完结
CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification
26天前
已完结
Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol
28天前
已完结
PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER+HER2- breast cancer harbouring acquired ESR1 mutations
1个月前
已完结
A Cyanobacteria-derived RNA aptamer resensitizes prostate cancer to hormone therapy
2个月前
已完结
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins
3个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
3个月前
已完结
CEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251
3个月前
已完结
皖公网安备34019202002308
